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Ever since their initial discovery few years ago, cyclic dinucleotides (cDNs), their biosynthesis, and their bio-
logical function have been in focus of intense research efforts. In this issue, Kato et al. (2015) present strong
evidence that the key enzyme in cDN biosynthesis, DncV, is poised on a tipping point such that, given a
nudge, the enzyme, can link the nucleotides into a distinct cyclic loop, leading to a specific innate immune
response.Cyclic dinucleotides (cDNs) are important
secondary messages in bacteria. Three
cDNs have been discovered so far: cyclic
di-GMP (cDG), cyclic di-AMP (cDA), and
the hybrid cyclic AMP-GMP (cGAMP)
(Commichau et al., 2015; Davies et al.,
2012; Romling et al., 2013). The cellular
cDN levels regulate many bacterial pro-
cesses via a number of mechanisms. For
example, cDG regulates microbial viru-
lence, motility, and biofilm formation
(Romling et al., 2013), and cDA is involved
in multiple functions, such as DNA repair,
cell-wall synthesis, potassium homeosta-
sis, and virulence (Commichau et al.,
2015). Interestingly, both a lack of and
high-level accumulation of cDA can be
harmful for the growth of bacteria. Firmi-
cutes such as B. subtilis are unable to
live without cDA, making cDA the only
known essential second messenger
(Mehne et al., 2013). The new type of
cDN, cGAMP, was recently identified as
a signaling molecule in V. cholerae that
is involved in virulence (Davies et al.,
2012). This hybridmolecule is synthesized
by the enzyme dinucleotide cyclase
(DncV), orthologs of which are predicted
to exist in many other bacterial species,
suggesting the important signaling roles
of cGAMP. DncV is particularly interesting
for its ability to synthesize not only the
hybrid cGAMP, but also non-hybrid cDG
and cDA (Davies et al., 2012).
Among the exciting achievements of
the intense research that followed the
discovery of the cDNs were the isolation
of the enzyme cyclic GMP-AMP synthase
or cGAS in mammals and its ability to syn-
thesize a cDN ligand that activated the
stimulator of interferon genes (STING)
(Sun et al., 2013; Wu et al., 2013). Furthercharacterization of cGAS showed that the
enzyme produces a cDN that has a rare
20-50 phosphodiester linkage between
GMP and AMP followed by a 30-50 return
linkage fromAMP to GMP. This is different
from all characterized cDNs, including
cAMP-GMP synthesized by DncV, which
is a 30-50, 30-50 isomer (Ablasser et al.,
2013; Davies et al., 2012). Given the simi-
larity in the nucleotidyl transferase (NT)
fold/domain of DncV and cGAS and the
fact that both enzymes make secondary
messenger molecules, it seems likely that
cGAS and DncV constitute a novel evolu-
tionarily conserved group that evolved to
detect cellular stimulus.
Although how cGAS could specifically
synthesize the 20-50, 30-50 cGAMP is
known from recent work (Civril et al.,
2013), how the bacteria DncV exclusively
make 30-50, 30-50 cDNs (cGAMP, cDA,
and cDG) remained unclear. In this work,
Kato et al. (2015) solved five high-resolu-
tion crystal structures of V. cholerae and
E. coli DncV in the apo form and in
complex with substrates, providing the
molecular basis for the bacteria-specific
mechanism of cDN production.
Like cGAS, DncV contains two nucleo-
tide-binding pockets for the acceptor
and donor, respectively. In both acceptor
and donor pockets, DncV binds the sub-
strate GTP or ATP mostly through the
base moiety, with fewer interactions with
the ribose and phosphate moieties. The
substrates are held in a way that the
30-OH group of the acceptor nucleotide
is proximal to the a-phosphate group of
the donor nucleotide and the catalytic
Asp193 residue (Figure 1A). DncV can
recognize both GTP and ATP by either
acceptor or donor pocket, giving DncVStructure 23, May 5, 2015the ability to synthesize all three cDNs
(cDG, cDA, and cGAMP). The donor
pocket recognizes GTP and ATP in similar
manners, but with more interaction with
GTP than ATP, suggesting a higher affinity
for GTP, and thereby DncV favors GTP
as the donor nucleotide. In contrast,
the acceptor pocket recognized GTP
and ATP in distinctive manners. In the
acceptor pocket, the 30-OH group of
ATP is closer than that of GTP (3.6 A˚
versus 4.4 A˚) and is in a better geometry,
which explains why DncV favors ATP
as the acceptor nucleotide (Figure 1A).
Therefore, the predominant production
of cGAMP by DncV in the presence of
both GTP and ATP is an outcome of
different binding affinity and reactive
orientation of the substrates in the two
pockets.
The next question is how DncV makes
only 30-50, 30-50 phosphodiester bond. In
this work, Kato et al. discovered that, no
matter whether GTP or ATP is held in the
acceptor pocket, the distance from the
30-OH group of acceptor to the a-phos-
phate group of the donor is closer than
that from the 20-OH group (in GTP case,
that is 0.6 A˚ closer). Therefore, DncV cat-
alyzes 30-50 phosphodiester formation in
the first step of the reaction. Distinctively,
the cGAS catalyzes 20-50 linkage in the
first step reaction. By structural compari-
son, Kato et al. showed that two different
acceptor-binding residues are respon-
sive for this distinct linkage specificity. In
DncV, the shorter Ile257 residue allows
deeper binding of the adenosine moiety,
leaving 30-OH group at the proximal posi-
tion for the reaction, whereas the corre-
sponding residue in porcine cGAS is a
longer Arg353 residue, which pushes theª2015 Elsevier Ltd All rights reserved 801
Figure 1. A Tipping Point for Making Discrete Cyclic Dinucleotides
(A) The acceptor pocket of DncV recognizes GTP and ATP in distinctive manners. Kato et al. (2015) show that the 30-OH group of ATP is bound in a better
geometry than that of GTP in acceptor pocket. In contrast, the donor pocket recognizes GTP and ATP in similarly, but with more interaction with GTP than
ATP, suggesting a higher affinity for GTP in the donor pocket.
(B) In DncV, the shorter acceptor binding residue Ile257 allows deeper binding of the adenosine moiety, leaving the 30-OH group at the proximal position for
reaction with phosphate from the donor GTP, whereas the corresponding residue in porcine cGAS is a longer Arg353 residue, which pushes the acceptor
ATP molecule more outside of the pocket, making instead the 20-OH more accessible for the reaction.
(C) With strict linkage specificity, the bacterial DncV and mammalian cGAS produce two different cGAMP isomers, each as an important secondary message in
the producing organisms.
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the pocket, making only 20-OH accessible
for the reaction (Figure 1B).
In the end, Kato et al. went on to explain
why DncV can’t be switched to cGAS-like
synthase by an Ile257Arg mutation. They
suggested that due to the different struc-
tural contexts of the DncV and cGAS
acceptor pockets, the side chain of the
mutated Arg257 is not fixed in the position
close to the acceptor nucleotide as in the
cGAS and thus failed to affect the orienta-
tion of the acceptor nucleotide. On the
other hand, the corresponding Arg376Ile
mutation of human cGAS did regain
the 30-50 cGAMP formation activity (Kran-
zusch et al., 2014).
Several questions remain for DncV. The
crystal structure of human cGAS revealed
a positively charged cleft adjacent to
the enzymatic scaffold. The positively
charged cleft specifically engages dsDNA
and induces structural rearrangement and
dimerization of cGAS, which are impor-
tant for the activation of cGAS (Kranzusch
et al., 2013). Intriguingly, despite retaining
the basic cleft, DncV does not require
dsDNA binding to stimulate enzymatic ac-802 Structure 23, May 5, 2015 ª2015 Elsevietivity (Davies et al., 2012; Kranzusch et al.,
2014). The possible role of the basic cleft
in DncV remains unknown. Additionally,
why DncV has evolved to make the 30-50,
30-50cGAMP and, in particular, whether
it has downstream receptor(s) other than
riboswitches (Nelson et al., 2015) remain
a mystery. Nonetheless, the thorough
structural analysis of DncV and deep un-
derstanding of its catalytic mechanism
pave the way for the rational design of
new antibacterial drugs targeting DncV,
which could affect a broad spectrum of
pathogenic bacteria.ACKNOWLEDGMENTS
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